Kedudukan dalam Saham
#11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Harga Saham
$4.48
Disegerakkan terakhir: 2026-08-28
Perubahan (1 hari)
-2.84%
Perubahan (1 tahun)
179.94%
Perdagangan OmniAb, Inc. (OABI)
Harga OABI dengan permodalan pasaran b
Modal pasaran bagi OmniAb, Inc.(OABI)
Modal Pasaran: $649.33M
Sehingga August 2026, OmniAb, Inc. mempunyai modal pasaran sebanyak $649.33M. Ini menjadikan OmniAb, Inc. syarikat ke-11871st paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran OmniAb, Inc. dari 2021 hingga 2026
OABI berbanding dengan 5 teratas yang paling popular stocks
| Harga OABI |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.264T
|
+810,558.71%
|
|
|
|
|
$4.701T
|
+723,917.10%
|
|
|
|
|
$4.177T
|
+643,203.69%
|
|
|
|
|
$3.817T
|
+587,796.51%
|
|
|
|
|
$2.866T
|
+441,328.44%
|
